Compare Elang Mahkota Teknologi Tbk. (EMTK) vs Organon Pharma Indonesia Tbk. (SCPI) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Elang Mahkota Teknologi Tbk. vs Organon Pharma Indonesia Tbk. — how do they compare? Elang Mahkota Teknologi Tbk. trades at Rp500 (market cap 30.71T, 52.1M 24h volume), while Organon Pharma Indonesia Tbk. trades at Rp29,000 (market cap 104.4B). The key difference: Elang Mahkota Teknologi Tbk. is far larger — about 294.2× Organon Pharma Indonesia Tbk.'s market cap. Which is the better fit depends on your goals.
| EMTK | SCPI | |
|---|---|---|
Market Cap | 30.71T | 104.4B |
Volume | 52.1M | — |
Lot | 520.97K | — |
Turnover | 25.95B | — |
Average Price | 498.1 | — |
Value | 25.95B | — |
Indicative Equilibrium Price | 500 | — |
Indicative Equilibrium Volume | 39.77K | — |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Elang Mahkota Teknologi Tbk.
PT Elang Mahkota Teknologi Tbk (the Company) was established based on Notarial Deed No.7 dated August 3, 1983 of Soetomo Ramelan, S.H.. The Company is engaged in services, specifically in providing technology, media, and telecommunication services, trading, construction, and industry. Company started its commercial operation in 1984.
Read more on EMTK →About Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Read more on SCPI →
